Monoclonal gammopathy of undetermined significance (MGUS) is an abnormal finding of a blood test. It means there’s a specific protein present in your blood and is an early sign of certain types of a ...

Monoclonal gammopathy of undetermined significance (MGUS) is when small amounts of antibodies called monoclonal antibodies (or M antibodies) are found in your blood. Normally, the plasma cells in your ...

Contrary to earlier studies, the not-entirely-rare condition known as monoclonal gammopathy of undetermined significance (MGUS) did not appear to raise risk for autoimmune disease when examined in the ...

The rate of MGUS among hospitalized patients over 50 was twice as high as that of the same age group in the general population. Higher rates of MGUS were prevalent among patients who had elevated ...

The risk for patients with monoclonal gammopathy of undetermined significance developing multiple myeloma is double if they have a specific category of rheumatic diseases compared with those without ...

Two recent papers shine a light on monoclonal gammopathy of undetermined significance (MGUS), a premalignant condition that is prevalent in the general population, affecting about 3% of individuals ...

Prediction of MGUS patients who will remain stable compared with those who progress is very difficult at the time of recognition of MGUS. However, the size of the M protein, type of M protein, number ...

If you have multiple myeloma, cancerous plasma cells divide and grow inside your bone marrow. Plasma cells are white blood cells that make antibodies. Antibodies are part of your immune system. They ...

Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...